Current role
Drew Deniger
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Alaunos Therapeutics, Inc. (TCRT)
Proxy statement
Current -
Alaunos Therapeutics, Inc. (TCRT)
Proxy statement
Start not stated–2023-11-15
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Alaunos Therapeutics, Inc. (TCRT) | VP, Research and Development | $317,757 | $629,680 |
| 2022 | Alaunos Therapeutics, Inc. (TCRT) | VP, Research and Development | $345,572 | $949,113 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.